pd 153035 and troglitazone

pd 153035 has been researched along with troglitazone in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (60.00)29.6817
2010's1 (20.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H1
Diggle, C; Holder, J; Lee, WC; Selby, PJ; Southgate, J; Stahlschmidt, J; Trejdosiewicz, LK; Varley, CL1
Smith, B; Southgate, J; Stahlschmidt, J; Stower, M; Varley, CL1
Aoi, T; Fujisawa, M; Hinata, N; Koyanagi-Aoi, M; Suzuki, K; Uehara, K1
Bergum, N; Garrett, SH; Knutson, P; Mehus, AA; Sens, DA; Sens, MA; Shrestha, S; Somji, S; Zhou, XD1

Other Studies

5 other study(ies) available for pd 153035 and troglitazone

ArticleYear
Identifying off-target effects and hidden phenotypes of drugs in human cells.
    Nature chemical biology, 2006, Volume: 2, Issue:6

    Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship

2006
Role of PPARgamma and EGFR signalling in the urothelial terminal differentiation programme.
    Journal of cell science, 2004, Apr-15, Volume: 117, Issue:Pt 10

    Topics: Active Transport, Cell Nucleus; Adipocytes; Anilides; Animals; Blotting, Western; Cattle; Cell Differentiation; Cell Line; Cell Proliferation; Chromans; Enzyme Inhibitors; Epidermal Growth Factor; Epithelium; ErbB Receptors; Gene Expression Regulation; Humans; Immunoprecipitation; Ligands; Membrane Glycoproteins; Membrane Proteins; Microscopy, Fluorescence; Phosphorylation; PPAR gamma; Promoter Regions, Genetic; Quinazolines; Ribonucleases; RNA, Messenger; Signal Transduction; Thiazolidinediones; Time Factors; Troglitazone; Uroplakin Ia; Uroplakin Ib; Uroplakin II; Uroplakin III; Urothelium

2004
Activation of peroxisome proliferator-activated receptor-gamma reverses squamous metaplasia and induces transitional differentiation in normal human urothelial cells.
    The American journal of pathology, 2004, Volume: 164, Issue:5

    Topics: Cell Differentiation; Chromans; Cloning, Molecular; DNA, Complementary; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Humans; Immunoblotting; Immunohistochemistry; Keratins; Metaplasia; Microscopy, Fluorescence; Quinazolines; Receptors, Cytoplasmic and Nuclear; Ribonucleases; RNA, Messenger; Signal Transduction; Thiazolidinediones; Transcription Factors; Troglitazone; Urothelium

2004
Directed differentiation of human induced pluripotent stem cells into mature stratified bladder urothelium.
    Scientific reports, 2019, 07-19, Volume: 9, Issue:1

    Topics: CDX2 Transcription Factor; Cell Differentiation; Cells, Cultured; Dextrans; Endoderm; ErbB Receptors; Fibroblast Growth Factor 10; Fluorescein-5-isothiocyanate; Glycogen Synthase Kinase 3 beta; Humans; Induced Pluripotent Stem Cells; Permeability; PPAR gamma; Pyridines; Pyrimidines; Quinazolines; Recombinant Proteins; Regenerative Medicine; SOXF Transcription Factors; Troglitazone; Urinary Bladder; Uroplakins; Urothelium

2019
Activation of PPARĪ³ and inhibition of cell proliferation reduces key proteins associated with the basal subtype of bladder cancer in As3+-transformed UROtsa cells.
    PloS one, 2020, Volume: 15, Issue:8

    Topics: Animals; Arsenites; Biomarkers, Tumor; Cell Line, Tumor; Cell Proliferation; Down-Regulation; ErbB Receptors; Hepatocyte Nuclear Factor 3-alpha; Humans; Keratins; Mice; Mice, Nude; PPAR gamma; Quinazolines; Transcription Factors; Transcriptome; Transplantation, Heterologous; Troglitazone; Up-Regulation; Urinary Bladder Neoplasms

2020